Wambolt & Associates, LLC Danaher Corp Transaction History

Wambolt & Associates, LLC

  • $366 Million
  • Q3 2024

A detailed history of Wambolt & Associates, LLC transactions in Danaher Corp stock. As of the latest transaction made, Wambolt & Associates, LLC holds 785 shares of DHR stock, worth $184,514. This represents 0.06% of its overall portfolio holdings.

Number of Shares
785
Holding current value
$184,514
% of portfolio
0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$239.25 - $280.76 $187,811 - $220,396
785 New
785 $218,000
Q4 2023

Feb 07, 2024
SELL
$185.1 - $233.13 $20,361 - $25,644
-110 Reduced 10.38%
950 $219,000
Q3 2023

Nov 06, 2023
SELL
$233.08 - $265.59 $3,729 - $4,249
-16 Reduced 1.49%
1,060 $262,000
Q2 2023

Aug 02, 2023
SELL
$224.99 - $256.14 $5,624 - $6,403
-25 Reduced 2.27%
1,076 $258,000
Q4 2022

Jan 31, 2023
BUY
$241.42 - $282.29 $19,796 - $23,147
82 Added 8.05%
1,101 $292,000
Q3 2022

Oct 18, 2022
BUY
$247.06 - $1507.4 $22,729 - $138,680
92 Added 9.92%
1,019 $263,000
Q2 2022

Aug 01, 2022
SELL
$237.11 - $299.66 $18,968 - $23,972
-80 Reduced 7.94%
927 $235,000
Q1 2022

May 10, 2022
SELL
$257.27 - $315.76 $7,203 - $8,841
-28 Reduced 2.71%
1,007 $294,000
Q4 2021

Feb 08, 2022
BUY
$292.08 - $329.01 $14,604 - $16,450
50 Added 5.08%
1,035 $341,000
Q3 2021

Oct 20, 2021
SELL
$272.21 - $332.43 $7,077 - $8,643
-26 Reduced 2.57%
985 $298,000
Q2 2021

Aug 13, 2021
SELL
$225.08 - $271.69 $3,601 - $4,347
-16 Reduced 1.56%
1,011 $275,000
Q4 2020

Jan 19, 2021
BUY
$212.5 - $245.46 $17,212 - $19,882
81 Added 8.56%
1,027 $228,000
Q3 2020

Nov 04, 2020
BUY
$177.16 - $215.33 $167,593 - $203,702
946 New
946 $204,000

Others Institutions Holding DHR

# of Institutions
2,508
Shares Held
542M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Wambolt & Associates, LLC Portfolio

Follow Wambolt & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wambolt & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wambolt & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email